LYMPHOBLASTIC LYMPHOMA
Clinical trials for LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine could shield transplant patients from deadly virus
⭐️ VACCINE ⭐️ OngoingThis study tests a vaccine designed to protect people who have had a stem cell transplant from a common virus called CMV. The virus can cause serious illness in those with weak immune systems. The vaccine uses a harmless virus to teach the body to fight CMV, aiming to reduce infe…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 19, 2026 12:01 UTC
-
New vaccine aims to shield transplant patients from deadly virus
Disease control OngoingThis study tests a vaccine called Triplex to see if it can prevent cytomegalovirus (CMV) infection in adults who have received a stem cell transplant. CMV is usually harmless but can be dangerous for people with weakened immune systems. The vaccine uses harmless pieces of CMV DNA…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New chemo combo aims to boost survival in kids with rare lymphoma
Disease control OngoingThis study tests a modified chemotherapy regimen (BFM backbone) in 150 Chinese children and teens with newly diagnosed lymphoblastic lymphoma. The goal is to improve event-free survival compared to earlier results. Participants receive intensive chemotherapy, and the trial is no …
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Liver shield: nutrient may prevent chemo side effects in young leukemia patients
Disease control OngoingThis study tests whether adding levocarnitine, a natural nutrient, to standard chemotherapy can prevent severe liver damage in teens and young adults (ages 15-39) with leukemia or lymphoma. Liver toxicity from the chemo drug asparaginase often delays treatment, especially in cert…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New chemo drug shows promise for kids with blood cancers
Disease control OngoingThis study tests a new form of chemotherapy called calaspargase pegol (SC-PEG) in 240 children and teens with acute lymphoblastic leukemia or lymphoblastic lymphoma. The goal is to see if giving it every 3 weeks is as safe and effective as the standard drug Oncaspar given every 2…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Parent training may boost school success for latino kids battling leukemia
Symptom relief OngoingThis study looks at whether training parents in specific skills can improve learning and school functioning for Latino children with acute leukemia or lymphoma. About 214 families will take part, with some parents receiving a high-intensity program and others getting standard sup…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 18, 2026 11:59 UTC
-
Digital coaching boosts learning for young cancer survivors
Knowledge-focused OngoingThis study tests whether a high-intensity digital health program—including video coaching and a special website—can help children aged 6 to 12 who were treated for leukemia or lymphoma improve their learning and school performance. Many children with these cancers are cured, but …
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 05:55 UTC
-
Scientists create tissue bank to unlock secrets of rare blood cancers
Knowledge-focused OngoingThis study collects bone marrow and blood samples, along with medical history, from people with multiple myeloma, Waldenstrom macroglobulinemia, and related conditions. The samples are stored in a tissue bank for researchers to study the causes and biology of these diseases. The …
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 05:53 UTC